Kenvue stock rebounds: Tylenol maker rises 6% after Donald Trump’s autism claims; analysts see limited legal impact
Kenvue shares rebounded after a sharp fall triggered by Donald Trump’s unfounded claims linking Tylenol to autism. Trump advised pregnant women to avoid the drug, ...
